Form 4 for DGX Quest Diagnostics
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001022079-26-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $204.86 | -188 | 8,508 | -2% | -$38.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | F | D | 188 | $204.86 | 8,508 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |